IL33 and cancer: Moreover, in IL-33 transgenic mice injected with melanoma and lung carcinoma cell lines, results revealed significantly increased tumor infiltration cytotoxic CD8+ T lymphocytes and natural killer cells compared to non-transgenic mice leading to cytolysis-mediated cancer cell death 14.